Order Article Reprints

Gerton TJ, Green A, Campisi M, Chen M, Gjeci I, Mahadevan N, Lee CAA, Mishra R, Vo HV, Haratani K, et al. Development of a Patient-Derived 3D Immuno-Oncology Platform to Potentiate Immunotherapy Responses in Ascites-Derived Circulating Tumor Cells. Cancers. 2023; 15(16):4128. https://doi.org/10.3390/cancers15164128

Gerton, Thomas J., Allen Green, Marco Campisi, Minyue Chen, Iliana Gjeci, Navin Mahadevan, Catherine A. A. Lee, Ranjan Mishra, Ha V. Vo, Koji Haratani, and et al. 2023. "Development of a Patient-Derived 3D Immuno-Oncology Platform to Potentiate Immunotherapy Responses in Ascites-Derived Circulating Tumor Cells" Cancers 15, no. 16: 4128. https://doi.org/10.3390/cancers15164128

Gerton, T. J., Green, A., Campisi, M., Chen, M., Gjeci, I., Mahadevan, N., Lee, C. A. A., Mishra, R., Vo, H. V., Haratani, K., Li, Z.-H., Hasselblatt, K. T., Testino, B., Connor, T., Lian, C. G., Elias, K. M., Lizotte, P., Ivanova, E. V., Barbie, D. A., & Dinulescu, D. M. (2023). Development of a Patient-Derived 3D Immuno-Oncology Platform to Potentiate Immunotherapy Responses in Ascites-Derived Circulating Tumor Cells. Cancers, 15(16), 4128. https://doi.org/10.3390/cancers15164128